FDA Approval Activities for this Drug… DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension, Bristol-Myers Squibb Medical Imaging, NDA 21-064/SCM-004 1/30/03 2/12/03 DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension, Bristol-Myers Squibb Medical Imaging, NDA 21-064/SLR-002 7/8/02 7/9/02 Definity, Bristol-Myers Squibb Medical Imaging, NDA 21-064/SLR-001 2/21/02 2/21/02 Definity (perflutren Lipid Microsphere) Injectable Suspension, DuPont Company NDA 21-064 7/31/01 05/08/03 11/1/01 Definity Indications: Use of activated Definity (perflutren Lipid Microsphere) Injectable Suspension in patients with suboptimal echocardiograms to opacity the left ventricular chamber and to improve the delineation of the left ventricular endocardial border. Back to this API's Main Page.

Browse other API's patent/exclusivity pages… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Find API by Brand Name | Industry Information | Prescription Drug Websites | Search | Site Map         © 2008 Betterchem Corp.